KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 114 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,020 | -25.1% | 3,000 | 0.0% | 0.00% | – |
| Q2 2023 | $5,370 | -54.0% | 3,000 | 0.0% | 0.00% | – |
| Q1 2023 | $11,670 | +14.4% | 3,000 | 0.0% | 0.00% | – |
| Q4 2022 | $10,200 | -36.2% | 3,000 | 0.0% | 0.00% | – |
| Q3 2022 | $16,000 | +14.3% | 3,000 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | -50.0% | 3,000 | -21.1% | 0.00% | – |
| Q1 2022 | $28,000 | +16.7% | 3,800 | 0.0% | 0.00% | – |
| Q4 2021 | $24,000 | +9.1% | 3,800 | 0.0% | 0.00% | – |
| Q3 2021 | $22,000 | -43.6% | 3,800 | 0.0% | 0.00% | – |
| Q2 2021 | $39,000 | -78.2% | 3,800 | -77.7% | 0.00% | – |
| Q1 2021 | $179,000 | -31.9% | 17,010 | 0.0% | 0.00% | – |
| Q4 2020 | $263,000 | +378.2% | 17,010 | +347.6% | 0.00% | – |
| Q3 2020 | $55,000 | -23.6% | 3,800 | 0.0% | 0.00% | – |
| Q2 2020 | $72,000 | -1.4% | 3,800 | 0.0% | 0.00% | – |
| Q1 2020 | $73,000 | 0.0% | 3,800 | 0.0% | 0.00% | – |
| Q4 2019 | $73,000 | +97.3% | 3,800 | 0.0% | 0.00% | – |
| Q3 2019 | $37,000 | +60.9% | 3,800 | 0.0% | 0.00% | – |
| Q2 2019 | $23,000 | +4.5% | 3,800 | 0.0% | 0.00% | – |
| Q1 2019 | $22,000 | -38.9% | 3,800 | 0.0% | 0.00% | – |
| Q4 2018 | $36,000 | +300.0% | 3,800 | +660.0% | 0.00% | – |
| Q3 2018 | $9,000 | +12.5% | 500 | 0.0% | 0.00% | – |
| Q2 2018 | $8,000 | +14.3% | 500 | 0.0% | 0.00% | – |
| Q1 2018 | $7,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
| TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
| Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
| Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
| Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
| Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
| SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
| Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |